Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)
- 1 September 1992
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 46 (3), 317-321
- https://doi.org/10.1016/0090-8258(92)90224-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: A preliminary analysisGynecologic Oncology, 1990
- Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamideGynecologic Oncology, 1990
- Uterine papillary serous carcinomaInternational Journal of Gynecology & Obstetrics, 1987
- Malignant papillary lesions of the endometriumGynecologic Oncology, 1987
- Therapeutic approaches to uterine papillary serous carcinoma: A preliminary reportGynecologic Oncology, 1987
- CA 125: A useful marker in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- Papillary Serous Adenocarcinoma of the EndometriumObstetrics & Gynecology, 1986
- Treatment of intraperitoneal metastatic adenocarcinoma of the endometrium by the whole-abdomen moving-strip technique and pelvic boost irradiationGynecologic Oncology, 1983
- Uterine papillary serous carcinomaThe American Journal of Surgical Pathology, 1982
- Survival Curve for Cancer Patients Following TreatmentJournal of the American Statistical Association, 1952